Co-Authors
This is a "connection" page, showing publications co-authored by CHRIS AMOS and CHAO CHENG.
Connection Strength
2.806
-
Germline HLA heterozygosity is associated with decreased lung cancer risk. HGG Adv. 2026 Apr 09; 7(2):100567.
Score: 0.244
-
Multiregional transcriptomic profiling provides improved prognostic insight in localized non-small cell lung cancer. NPJ Precis Oncol. 2024 Oct 05; 8(1):225.
Score: 0.223
-
The prognostic effect of infiltrating immune cells is shaped by proximal M2 macrophages in lung adenocarcinoma. Mol Cancer. 2024 Sep 04; 23(1):185.
Score: 0.222
-
Racial and socioeconomic disparities in survival improvement of eight cancers. BJC Rep. 2024 Mar 11; 2(1):21.
Score: 0.215
-
Clonal gene signatures predict prognosis in mesothelioma and lung adenocarcinoma. NPJ Precis Oncol. 2024 Feb 23; 8(1):47.
Score: 0.214
-
A combination of intrinsic and extrinsic features improves prognostic prediction in malignant pleural mesothelioma. Br J Cancer. 2022 11; 127(9):1691-1700.
Score: 0.193
-
Genetic variants associated mRNA stability in lung. BMC Genomics. 2022 Mar 11; 23(1):196.
Score: 0.187
-
A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma. Genome Med. 2022 01 12; 14(1):5.
Score: 0.185
-
Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. Cancer Res. 2022 01 15; 82(2):199-209.
Score: 0.183
-
Statins associate with improved mortality among patients with certain histological subtypes of lung cancer. Lung Cancer. 2018 12; 126:89-96.
Score: 0.148
-
Predictors of disease aggressiveness influence outcome from immunotherapy treatment in renal clear cell carcinoma. Oncoimmunology. 2019; 8(1):e1500106.
Score: 0.148
-
Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics. Melanoma Res. 2018 10; 28(5):380-389.
Score: 0.147
-
A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis. Mol Cancer Res. 2019 01; 17(1):109-119.
Score: 0.146
-
Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy. Oncoimmunology. 2018; 7(6):e1431084.
Score: 0.142
-
A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2018 01; 27(1):86-95.
Score: 0.139
-
Characterizing the heterogeneity in 5-aminolevulinic acid-induced fluorescence in glioblastoma. J Neurosurg. 2020 06 01; 132(6):1706-1714.
Score: 0.038
-
Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients. PLoS One. 2017; 12(4):e0175850.
Score: 0.033